Osteoporosis en hombres de la consulta de endocrinología en la ciudad de Manizales, Colombia

Kanis, 2008, A reference standard for the description of osteoporosis, Bone., 42, 467, 10.1016/j.bone.2007.11.001 Pouresmaeili, 2018, A comprehensive overview on osteoporosis and its risk factors, Ther Clin Risk Manag., 14, 2029, 10.2147/TCRM.S138000 Willson, 2015, The Clinical epidemiology of male osteoporosis: a review of the recent literature, Clin Epidemiol., 7, 65 Ducharme, 2010, Male osteoporosis, Clin Geriatr Med., 26, 301, 10.1016/j.cger.2010.02.005 Adler, 2018, Update on osteoporosis in men, Best Pract Res Clin Endocrinol Metab., 32, 759, 10.1016/j.beem.2018.05.007 Gennari, 2007, Osteoporosis in men, Endocrinol Metab Clin North Am., 36, 399, 10.1016/j.ecl.2007.03.008 Mirza, 2015, Management of endocrine disease: Secondary osteoporosis: pathophysiology and management, Eur J Endocrinol., 173, 1, 10.1530/EJE-15-0118 WHO Technical Report Series 843. Assessment of fracture risk and its application to screening for posmenopausal osteoporosis. Report of a WHO Study Group. Geneva: World Health Organization; 1994 [consultado 9 Abr 2019]. Disponible en: https://apps.who.int/iris/bitstream/10665/39142/1/WHO TRS 843 eng.pdf The International Society for Clinical Densitometry. Official positions adult and pediatrics. Middletown; 2015 [consultado 9 Abr 2019]. Disponible en: https://iscd.app.box.com/v/OP-ISCD-2015-Adult WHO. Physical Status: The Use and Interpretation of Anthropometry: Report of a World Health Organization (WHO) Expert Committee. Geneva, Switzerland: World Health Organization; 1995 [consultado 13 Abr 2019] Disponible en: https://apps.who.int/iris/bitstream/handle/10665/37003/WHO_TRS_854.pdf Alejandro, 2017, A review of osteoporosis in the older adult, Clin Geriatr Med., 33, 27, 10.1016/j.cger.2016.08.003 Morales-Torres, 2004, The burden of osteoporosis in Latin America, Osteoporos Int., 15, 625, 10.1007/s00198-004-1596-3 Jaller, 2007, Osteoporosis y factores de riesgo en una población masculina latinoamericana, Rev Colomb Reumatol., 14, 99 Pereira, 2010, Epidemiología de la osteoporosis en una población masculina, Med Interna., 26, 124 Medina, 2018, Características clínicas de los pacientes con fracturas por fragilidad, Repert Med Cir., 27, 30, 10.31260/RepertMedCir.v27.n1.2018.129 González, 2009, Epidemiología de la osteoporosis, Rev Colomb Reumatol., 16, 61 Gielen, 2011, Osteoporosis in men, Best Pract Res Clin Endocrinol Metab., 25, 321, 10.1016/j.beem.2010.08.012 Hudec, 2013, Secondary causes of osteoporosis, Endocr Pract., 19, 120, 10.4158/EP12059.RA Caballero-Uribe, 2008, Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city, J Clin Rheumatol., 14, 153, 10.1097/RHU.0b013e31816b1931 Emkey, 2014, Secondary osteoporosis: pathophysiology & diagnosis, Best Pract Res Clin Endocrinol Metab., 28, 911, 10.1016/j.beem.2014.07.002 Machado, 2013, Baja frecuencia de prescripción de profilaxis para osteoporosis en pacientes en tratamiento crónico con corticoides en Colombia, Rev Peru Med Exp Salud Publica., 30, 26, 10.1590/S1726-46342013000100005 Ryan, 2011, Osteoporosis in men: the value of laboratory testing, Osteoporos Int., 22, 1845, 10.1007/s00198-010-1421-0 Aparisi Gómez, 2016, Nonspinal fragility fractures, Semin Musculoskelet Radiol., 20, 330, 10.1055/s-0036-1592434 Drake, 2012, Male osteoporosis, Endocrinol Metab Clin North Am., 41, 629, 10.1016/j.ecl.2012.05.001 Escorial, 2011, ¿Se fracturan la cadera los hombres y las mujeres ante los mismos factores de riesgo?, Rev Clin Esp., 211, 495, 10.1016/j.rce.2011.05.017 Zapata, 2016, Osteoporosis del varón: hallazgos clínicos y de la densitometría ósea en 70 casos, Rev Chil Endocrinol Diabetes., 9, 11 O’Neill, 1996, The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study, J Bone Miner Res., 11, 1010, 10.1002/jbmr.5650110719 Center, 2007, Risk of subsequent fracture after low-trauma fracture in men and women, JAMA., 297, 387, 10.1001/jama.297.4.387 Rosen, 2011, Clinical practice vitamin D insufficiency, N Engl J Med., 364, 248, 10.1056/NEJMcp1009570 Looker, 2002, Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III, Bone., 30, 771, 10.1016/S8756-3282(02)00692-0 Saraiva, 2007, Prevalence of vitamin D deficiency, insufficiency and secondary hyperparathyroidism in the elderly inpatients and living in the community of the city of São Paulo, Brazil, Arq Bras Endocrinol Metabol., 51, 437, 10.1590/S0004-27302007000300012 Navarro, 2016, Prevalencia de la insuficiencia de vitamina D en pacientes con osteoporosis, Rev Colomb Reumatol., 23, 17 Nayak, 2017, Osteoporosis treatment efficacy for men: a systematic review and meta-analysis, J Am Geriatr Soc., 65, 490, 10.1111/jgs.14668 Lyles, 2007, Zoledronic acid and clinical fractures and mortality after hip fracture, N Engl J Med., 357, 1799, 10.1056/NEJMoa074941 Boonen, 2012, Fracture risk and zoledronic acid therapy in men with osteoporosis, N Engl J Med., 367, 1714, 10.1056/NEJMoa1204061 Orwoll, 2003, The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis, J Bone Miner Res., 18, 9, 10.1359/jbmr.2003.18.1.9 Kaufman, 2005, Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy, Osteoporos Int., 16, 510, 10.1007/s00198-004-1713-3 Orwoll, 2012, A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density, J Clin Endocrinol Metab., 97, 3161, 10.1210/jc.2012-1569 Suárez, 2011, Estudio de causas secundarias de osteoporosis masculina, Rev Argent Endocrinol Metab., 48, 87 De Felipe, 2010, Características clínicas de los pacientes con tratamiento para la osteoporosis en un centro de Atención Primaria: ¿a quién tratamos en nuestras consultas?, Aten Primaria., 42, 559, 10.1016/j.aprim.2009.10.022